全覆膜自膨式金属支架扩张慢性胰腺炎持续性胰管狭窄:前瞻性研究的长期随访
这项前瞻性单臂试验纳入15例慢性胰腺炎合并症状性主胰管狭窄患者,在单根塑料支架置入后狭窄持续3个月以上者置入镍钛合金全覆膜自膨式金属支架(FC-SEMS),6个月后取出。所有病例支架均可取出,最终9例胰管狭窄缓解者平均随访38.9个月,89%无症状。
要点
- FC-SEMS在主胰管中取出可行,全部病例成功取出。
- 最终9例胰管狭窄缓解者平均随访38.9个月,89%无症状。
- 3 cm长FC-SEMS完全远端移位7例(47%),FC-SEMS诱发性狭窄4例(27%)。
核心结论
- 慢性胰腺炎主胰管FC-SEMS取出在所有病例中可行,90%的患者3年后无症状。
- 3 cm长FC-SEMS移位似乎更常见,FC-SEMS诱发性胰腺狭窄是主要问题,值得进一步评估。
- 作者认为胰腺FC-SEMS结果有前景,但需要在临床试验背景下仔细评估。
研究设计与样本
- 前瞻性单臂试验,2012年12月至2014年10月纳入15例慢性胰腺炎合并症状性主胰管狭窄(位于胰头,单根塑料支架置入后持续3个月或以上)患者。
- 置入镍钛合金FC-SEMS,6个月后取出;支架直径和长度根据狭窄解剖和狭窄上方主胰管直径选择。
- 主要目标为FC-SEMS可取出性;次要结局为主胰管狭窄缓解率和不良事件。
主要发现
- 15例患者中10例男性,平均年龄60岁;胰腺钙化6例(40%),酒精滥用史4例(27%)。
- 10例经主乳头置入FC-SEMS,5例(3例胰腺分裂,2例主导背胰管)经副乳头置入。
- 1例在24小时后发生胆管炎,因FC-SEMS遮挡胆道括约肌切开处所致,置入塑料胆道支架后胆管炎缓解。
- FC-SEMS完全远端移位7例(47%)(5例无症状,2例有症状伴胰腺炎复发),所有移位均发生于3 cm长FC-SEMS。
- 4例(27%)在FC-SEMS喇叭端水平发生FC-SEMS诱发性新生狭窄并被排除随访;1例FC-SEMS移位者狭窄未缓解;1例失访。
临床怎么用
- 原文未据此给出推荐。
局限性
- 4例(27%)发生FC-SEMS诱发性胰腺狭窄,作者称其为主要问题并值得进一步评估。
- 作者认为胰腺FC-SEMS结果有前景,但需要在临床试验背景下仔细评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Symptomatic main pancreatic duct (MPD) strictures secondary to chronic pancreatitis (CP) may benefit from endoscopic insertion of single or multiple plastic stents. MPD stricture resolution after single plastic stent removal is uncommon. The use of removable fully covered, self-expandable metal stents (FC-SEMSs) to dilate MPD strictures secondary to CP was evaluated. METHODS: Patients with CP and symptomatic MPD stricture located in the head of the pancreas persisting for 3 months or more after placement of a single plastic stent were enrolled in a prospective single-arm trial. A nitinol FC-SEMS was inserted and removed after 6 months. The FC-SEMS diameter and length were chosen according to the stricture anatomy and MPD diameter above the stricture. Our primary objective was FC-SEMS removability. Secondary outcomes were MPD stricture resolution rate and adverse events. RESULTS: Between December 2012 and October 2014, 15 patients (10 male, mean age 60 years) were enrolled. Pancreatic calcifications were present in 6 (40%) patients. Four patients (27%) had a history of alcohol abuse. In 10 patients, the FC-SEMS was inserted through the major papilla, whereas 5 patients (3 pancreas divisum, 2 dominant dorsal duct) received the stent through the minor papilla. One patient developed cholangitis after 24 hours due to occlusion of the biliary sphincterotomy from the FC-SEMS; cholangitis resolved after insertion of a plastic biliary stent. Complete distal migration of the FC-SEMS was reported in 7 patients (47%) (5 asymptomatic, 2 symptomatic with recurrence of pancreatitis). All migrations occurred with the 3-cm-long FC-SEMS. Four patients (27%) developed de novo stricture induced by the FC-SEMS at the level of the flared end and were excluded from the follow-up; 1 patient with FC-SEMS migration had failed stricture resolution. One patient was lost to follow-up. Finally, 9 patients with MPD stricture resolution had a mean follow-up of 38.9 months (range, 5.3-55.3 months), and 89% were asymptomatic. CONCLUSIONS: FC-SEMS removability from the MPD in CP was feasible in all cases, and 90% of the patients were asymptomatic after 3 years. Migration seems more frequent with the 3-cm-long FC-SEMS. Occurrence of FC-SEMS-induced pancreatic strictures is a major issue and deserves further assessment. According to our experience, pancreatic FC-SEMSs have promising results, but a careful evaluation in the setting of clinical trials is needed.
引用
- Tringali A, Vadalà di Prampero SF, Landi R, et al. Fully covered self-expandable metal stents to dilate persistent pancreatic strictures in chronic pancreatitis: long-term follow-up from a prospective study. Gastrointest Endosc. 2018. PMID: 30142349. doi:10.1016/j.gie.2018.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。